Nippon India Pharma Fund - Direct Plan - Growth Plan
Nippon India Pharma Fund - Direct Plan - Growth Plan

Nippon India Pharma Fund - Direct Plan - Growth Plan

Equity
Direct
Very High Risk
Sector - Healthcare

NAV: ₹ 304.1 as on 17-08-2022

INDmoney Rank

Powered by IND quant engine
IND ranking is not available for this fund.
Pros
5Y returns in the top 25% of the category
3Y returns in the top 25% of the category
Among most bought funds within the category
Cons
No bad points found for this fund.
About the Fund

Nippon India Pharma Fund - Direct Plan - Growth Plan is an equity fund. This fund was started on  1 January, 2013. The fund is managed by Sailesh Raj Bhan, Kinjal Desai. The fund could potentially beat inflation in the long-run.

Key parameters

1) Nippon India Pharma Fund - Direct Plan - Growth Plan has a NAV of 304.0983 as on 17-08-2022.

2) Nippon India Pharma Fund - Direct Plan - Growth Plan has 4620 Cr worth of assets under management (AUM) as on 30-06-2022 and is more than category average.

3) The fund has an expense ratio 1.06 %.

Fund Overview

Expense ratio
Expense ratio
1.06%
Benchmark
Benchmark
S&P BSE Healthcare PR
AUM
AUM
₹4620 Cr
Inception Date
Inception Date
1 January, 2013
Min Lumpsum/SIP
Min Lumpsum/SIP
₹5000/₹100
Exit Load
Exit Load
1%
Lock In
Lock In
No Lock-in
TurnOver
TurnOver
55.36%

Fund Distribution

  • Equity 99.4%
  • Debt & Cash 0.7%
Size breakup
Large cap
50.5%
Mid cap
27%
Small cap
21.8%
Sector Allocation
Health100%

Top Holdings

  • All
  • Equity
  • Debt & Cash
Total Holdings23
Equity Holdings20
Debt Holdings3
Holdings
Weight%
No. of Shares (4M)
1M Change
icon
Sun Pharmaceuticals Industries Ltd
14.9%
0%
icon
Cipla Ltd
8.5%
0%
icon
Dr Reddy's Laboratories Ltd
7.5%
6.3%
icon
Divi's Laboratories Ltd
7.5%
0%
icon
Torrent Pharmaceuticals Ltd
6.5%
-7.5%

What changed

in last one month
  • Scheme
  • Portfolio
AUM increased by 219.2 Cr in last 1M
Jul'22 return underperformed benchmark

Change in AUM

Jul'22
₹ 4.6K Cr
Jun'22
₹ 4.4K Cr
May'22
₹ 4.5K Cr

Fund Returns vs Benchmark

Jul'22
5.47%
9.49%
Jun'22
-2.36%
-4.94%
Fund Return
Benchmark Return

Concentration Analysis

Fund
Jun'22
May'22
Apr'22
No of Holdings
30
30
31
Top 5 Company Concentration
44.4%
44.4%
44.3%
Company having highest exposure
Sun Pharmaceuticals Industries Ltd (13.8%)
Sun Pharmaceuticals Industries Ltd (13.9%)
Sun Pharmaceuticals Industries Ltd (14%)
No of Sectors
2
2
2
Top 5 Sectors Concentration
100%
100%
100%
Sector having highest exposure
Health (99%)
Health (98.3%)
Health (98.7%)

Fund Manager

Sailesh Raj Bhan

Sailesh Raj Bhan

Managing this fund since 1 April 2005
Years of Experience
19
Years of Experience

Top funds managed

Scheme
Annualised Returns(3Y)
Category Returns(3Y)
Nippon India Large Cap Fund - Direct Plan - Growth Plan
19.99%
17.88%
Nippon India Multi Cap Fund - Direct Plan - Growth
22.66%
22.18%
Nippon India Pharma Fund - Direct Plan - Growth Plan
27.84%
25.78%
Kinjal Desai

Kinjal Desai

Managing this fund since 25 May 2018
Years of Experience
10
Years of Experience

Top funds managed

Scheme
Annualised Returns(3Y)
Category Returns(3Y)
Nippon India Liquid Fund Direct Plan Growth Plan
4.15%
3.22%
Nippon India Small Cap Fund - Direct Plan - Growth Plan
36.86%
32.45%
Nippon India Multi Cap Fund - Direct Plan - Growth
22.66%
22.18%

AMC details

Address
Nippon Life India Asset Management Limited,4th Floor, Tower A, Peninsula Business Park,,Ganapatrao Kadam Marg,,Lower Parel (W)
Phone
022-68087000/18602660111
Fund House
Nippon Life India Asset Management Ltd

Fund Highlights

About the fund

About the fund

This fund has delivered an average annual returns of 16.53% since inception which is less than its category average return of 19.93%
Fund Allocations

Fund Allocations

This fund has an allocation of 99.35% in Equity, 0% in Debt and 0.65% in Cash related instruments
AUM size ₹4620 Cr

AUM size ₹4620 Cr

This fund has AUM of ₹4620 Cr which is more than its category average of ₹ 1353 Cr
Expense Ratio 1.06%

Expense Ratio 1.06%

This fund has an expense ratio of 1.06% which is less than its category average expense ratio of 1.57%
meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk

Frequently Asked Questions

What are the average returns of Nippon India Pharma Fund - Direct Plan - Growth Plan Fund ?

What is the current NAV of Nippon India Pharma Fund - Direct Plan - Growth Plan Fund?

How do I invest in Nippon India Pharma Fund - Direct Plan - Growth Plan Fund?

What is the expense ratio of Nippon India Pharma Fund - Direct Plan - Growth Plan fund?

What is the worth of total assets under management (AUM) of Nippon India Pharma Fund - Direct Plan - Growth Plan fund ?

What are the top holdings of Nippon India Pharma Fund - Direct Plan - Growth Plan Fund?

What are the top sectors Nippon India Pharma Fund - Direct Plan - Growth Plan Fund has invested in?